Earn up to 0.5 AMA PRA Category 1 CME credits for the “How to Assess Second-Line Diabetes Agents for Patients at Risk for Major Osteoporotic Fractures” interactive case study that allows you to follow a patient through key stages and decision points in her diabetes care.
You are here
What are the best ways to help prevent your type 2 diabetes patient avoid major osteoporotic fractures many diabetes medications can actually increase the risk of fracture? This interactive case study features can exploration of current science, clinical recommendations and medication options. The case study provides insights into mitigating fracture risk while effectively treating type 2 diabetes.
For the first time, medications are available that can help type 2 diabetes patients control their glucose and help reduce their cardiovascular event risk. Drs. Doron Schneider and Bernard Zinman explore how to incorporate them into patient care.
Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD. (50:19)
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD
A 38-year-old Caucasian male presents to your office reporting symptoms of fatigue, thirst, and weight loss. He has not been to a physician since his late 20s. Your physical examination shows high blood pressure (150/96 mmHg) and a BMI (body-mass index) of 36 kg/m2. There is a family history of cardiovascular disease, although the patient himself reports having no personal history of cardiac symptoms or cardiovascular events.
- Page 1 of 6